Works matching IS 11707690 AND DT 2025 AND VI 43 AND IP 4

Results: 8

Projections of Public Spending on Pharmaceuticals: A Review of Methods: Projections of Public Spending on Pharmaceuticals: I. Odnoletkova et al.

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 375, doi. 10.1007/s40273-024-01465-w

By:

Odnoletkova, Irina;
Chalon, Patrice X.;
Devriese, Stephan;
Cleemput, Irina

Publication type:

Article

Home Urine Dipstick Screening for Bladder and Kidney Cancer in High-Risk Populations in England: A Microsimulation Study of Long-Term Impact and Cost-Effectiveness: Cost-Effectiveness of Bladder Cancer Screening: Microsimulation: O. Mandrik et al.

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 441, doi. 10.1007/s40273-024-01463-y

By:

Mandrik, Olena;
Thomas, Chloe;
Akpan, Edifofon;
Catto, James W. F.;
Chilcott, Jim

Publication type:

Article

Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma: CEA of Exclusionary EGFR Testing: H.-T. Ou et al.

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 429, doi. 10.1007/s40273-024-01462-z

By:

Ou, Huang-Tz;
Tsai, Jui-Hung;
Chen, Yi-Lin;
Wu, Tzu-I.;
Chen, Li-Jun;
Yang, Szu-Chun

Publication type:

Article

Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment: Value of Innovative Multiple Myeloma Treatments: S. Syeed et al.

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 403, doi. 10.1007/s40273-024-01459-8

By:

Syeed, Sakil;
Tan, Chia Jie;
Godara, Amandeep;
Gooden, Kyna;
Tang, Derek;
Slaff, Samantha;
Shih, Yu-Hsuan;
Ngorsuraches, Surachat;
Chaiyakunapruk, Nathorn

Publication type:

Article

Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study: Estimating Productivity Losses in an Economic Evaluation: Case Study Using Foodborne Illness: K. Manipis et al.

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 453, doi. 10.1007/s40273-024-01458-9

By:

Manipis, Kathleen;
Cronin, Paula;
Street, Deborah;
Church, Jody;
Viney, Rosalie;
Goodall, Stephen

Publication type:

Article

How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Differences Analyses Using the UK Household Longitudinal Survey: How Does Bereavement Affect the Health-Related Quality of Life: B. Pennington et al

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 389, doi. 10.1007/s40273-024-01452-1

By:

Pennington, Becky;
Hernández Alava, Mónica;
Strong, Mark

Publication type:

Article

A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence: Pricing and Reimbursement of New Pharmaceuticals in an Evolving Landscape: B. Woods et al

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 363, doi. 10.1007/s40273-024-01450-3

By:

Woods, Beth;
Palacios, Alfredo;
Sculpher, Mark

Publication type:

Article

Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs: Indication-Specific Pricing and Weighted-Average Pricing: D. T. Michaeli, T. Michaeli.

Published in:

PharmacoEconomics, 2025, v. 43, n. 4, p. 415, doi. 10.1007/s40273-024-01448-x

By:

Michaeli, Daniel Tobias;
Michaeli, Thomas

Publication type:

Article